|
|
|
|
| LEADER |
00809Cam#a2200253#a#4500 |
| 001 |
OMD003122 |
| 003 |
OMD |
| 005 |
20160810093036 |
| 008 |
||||||s1998 sz f |||| ||eng d |
| 020 |
# |
# |
|a 9241545224 (OC)
|
| 040 |
# |
# |
|a OMD
|b spa
|
| 060 |
# |
4 |
|a WE
|b 250
|
| 092 |
# |
# |
|s OMS
|c WE 250
|l GUI
|
| 110 |
2 |
# |
|a World Health Organization.
|
| 245 |
1 |
0 |
|a Guidelines for preclinical evaluation and clinical trials in osteoporosis /
|c World Health Organization.
|
| 260 |
# |
# |
|a Geneva :
|b WHO,
|c 1998.
|
| 300 |
# |
# |
|a vi, 68 p.
|
| 650 |
# |
7 |
|a Osteoporosis/terapia
|2 Decs
|
| 650 |
# |
7 |
|a Legislación de medicamentos
|2 Decs
|
| 650 |
# |
7 |
|a Ensayos clínicos/métodos
|2 Decs
|
| 650 |
# |
7 |
|a Organización Mundial de la Salud
|2 Decs
|
| 866 |
# |
0 |
|a 1 ej.
|
| 952 |
# |
# |
|p OMD26327
|a OMD
|b OMD
|o OMS WE 250 GUI [DEPOSITO]
|y IMP
|t ej.1
|7 1
|
| 999 |
# |
# |
|a Andrea
|
